Form 4: Neumora COO Sells Shares for Tax Obligations

Neumora Therapeutics' Chief Operating and Development Officer, Daljit Singh Aurora, sold 6,165 shares of common stock to cover tax withholding obligations.

Summary

• Daljit Singh Aurora, Chief Operating and Development Officer of Neumora Therapeutics, Inc. (NMRA), reported a transaction involving the company's common stock.
• On February 17, 2026, Aurora sold 6,165 shares of common stock at a price of $3.555 per share.
• The sale was conducted to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• Following this transaction, Aurora directly beneficially owns 82,770 shares of Neumora Therapeutics common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale of shares is explicitly for tax withholding purposes related to RSU vesting, a common and expected occurrence for executives.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive stock ownership changes. This specific transaction, being for tax withholding, is a common occurrence and typically does not signal a change in management's outlook on the company's prospects, unlike open market sales.

Stakeholder Impact

• Shareholders: Minor dilution from the sale, but the transaction is routine and unlikely to significantly impact shareholder value or perception.

Key Dates

Recommendation

The transaction reported is a routine sale of shares by an officer to cover tax obligations associated with the vesting of restricted stock units. This type of insider transaction is common and generally does not reflect a change in the officer's confidence in the company's future or warrant a change in investment recommendation based solely on this filing.

Keywords

Neumora Therapeutics, NMRA, Daljit Singh Aurora, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Officer Transaction